Utility of Serum 1,3-β-d-Glucan Testing for Diagnosis and Prognostication in COVID-19-Associated Pulmonary Aspergillosis.
作者信息
Egger Matthias, Prüller Florian, Krause Robert, Prattes Juergen, Hoenigl Martin
机构信息
Division of Infectious Diseases, Department of Internal Medicine, Medical University of Grazgrid.11598.34, Graz, Austria.
BioTechMed-Graz, Graz, Austria.
出版信息
Microbiol Spectr. 2022 Jun 29;10(3):e0137322. doi: 10.1128/spectrum.01373-22. Epub 2022 May 31.
Abstract
摘要
相似文献
1
Utility of Serum 1,3-β-d-Glucan Testing for Diagnosis and Prognostication in COVID-19-Associated Pulmonary Aspergillosis.血清1,3-β -d-葡聚糖检测在新型冠状病毒肺炎相关肺曲霉病诊断和预后评估中的应用
Microbiol Spectr. 2022 Jun 29;10(3):e0137322. doi: 10.1128/spectrum.01373-22. Epub 2022 May 31.
2
COVID-Associated Pulmonary Aspergillosis in the United States: Is It Rare or Have We Missed the Diagnosis?美国的新型冠状病毒肺炎相关肺曲霉病：是罕见还是我们漏诊了？
J Clin Microbiol. 2021 Sep 20;59(10):e0113521. doi: 10.1128/JCM.01135-21. Epub 2021 Jul 21.
3
Prospective Evaluation of the Turbidimetric β-D-Glucan Assay and 2 Lateral Flow Assays on Serum in Invasive Aspergillosis.侵袭性曲霉病患者血清中比浊法β-D-葡聚糖检测和 2 种侧向流检测的前瞻性评估。
Clin Infect Dis. 2021 May 4;72(9):1577-1584. doi: 10.1093/cid/ciaa295.
4
[Evaluation of (1-3)-beta-D-glucan in aspergillosis and cryptococcosis].(1-3)-β-D-葡聚糖在曲霉病和隐球菌病中的评估
Nihon Kyobu Shikkan Gakkai Zasshi. 1994 Jan;32(1):37-41.
5
Usefulness of Two Aspergillus PCR Assays and Aspergillus Galactomannan and β-d-Glucan Testing of Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis.两种曲霉聚合酶链反应检测以及支气管肺泡灌洗液曲霉半乳甘露聚糖和β - d - 葡聚糖检测在慢性肺曲霉病诊断中的应用价值
J Clin Microbiol. 2017 Jun;55(6):1738-1746. doi: 10.1128/JCM.02497-16. Epub 2017 Mar 22.
6
Detecting influenza-associated pulmonary aspergillosis by determination of galactomannan in broncho-alveolar lavage fluid and in serum: should we add (1,3)-beta-D-glucan to improve efficacy.通过测定支气管肺泡灌洗液和血清中的半乳甘露聚糖来检测流感相关的肺曲霉病：我们是否应添加（1,3）-β-D-葡聚糖以提高检测效果。
Crit Care. 2020 Jun 5;24(1):294. doi: 10.1186/s13054-020-03030-1.
7
Comparison of PCR, (1-->3)-beta-D-glucan and galactomannan assays in sera of rats with experimental invasive aspergillosis.实验性侵袭性曲霉病大鼠血清中PCR、（1→3）-β-D-葡聚糖和半乳甘露聚糖检测的比较
J Clin Lab Anal. 1998;12(5):257-62. doi: 10.1002/(SICI)1098-2825(1998)12:5<257::AID-JCLA1>3.0.CO;2-3.
8
[Evaluation of galactomannan antigen and beta-D-glucan value for diagnosis of chronic necrotizing pulmomary aspergillosis].[半乳甘露聚糖抗原及β-D-葡聚糖值在慢性坏死性肺曲霉病诊断中的评估]
Nihon Kokyuki Gakkai Zasshi. 2009 Jan;47(1):7-11.
9
Usefulness of Sōna Aspergillus Galactomannan LFA with digital readout as diagnostic and as screening tool of COVID-19 associated pulmonary aspergillosis in critically ill patients. Data from a multicenter prospective study performed in Argentina.Sōna Aspergillus Galactomannan LFA 与数字读数在危重症 COVID-19 相关肺曲霉病中的诊断和筛查工具的效用。来自阿根廷进行的一项多中心前瞻性研究的数据。
Med Mycol. 2022 May 18;60(5). doi: 10.1093/mmy/myac026.
10
Evaluation of galactomannan and beta-d-glucan assays for the diagnosis of invasive aspergillosis in clinically suspected cases.评价半乳甘露聚糖和β-葡聚糖检测对临床疑似侵袭性曲霉病的诊断价值。
J Pak Med Assoc. 2020 Mar;70(3):442-446. doi: 10.5455/JPMA.1476.
引用本文的文献
1
[S1 guideline: diagnosis and treatment of invasive pulmonary aspergillosis in critically ill/intensive care patients].[S1 指南：危重症/重症监护患者侵袭性肺曲霉病的诊断与治疗]
Med Klin Intensivmed Notfmed. 2025 May;120(4):271-289. doi: 10.1007/s00063-025-01265-w. Epub 2025 Mar 21.
2
Fatal invasive Aspergillus infection in an elderly patient with hepatitis E: A case report and literature review.老年戊型肝炎患者合并侵袭性曲霉病致死：病例报告并文献复习
Medicine (Baltimore). 2024 Oct 25;103(43):e40103. doi: 10.1097/MD.0000000000040103.
3
Exploring European Consensus About the Remaining Treatment Challenges and Subsequent Opportunities to Improve the Management of Invasive Fungal Infection (IFI) in the Intensive Care Unit.探讨欧洲对于侵袭性真菌感染（IFI）在重症监护病房管理方面尚存治疗挑战和后续改进机会的共识。
Mycopathologia. 2024 May 5;189(3):41. doi: 10.1007/s11046-024-00852-3.
4
Metagenomic Next-Generation Sequencing of Plasma for Diagnosis of COVID-19-Associated Pulmonary Aspergillosis.血浆宏基因组下一代测序在 COVID-19 相关肺曲霉病诊断中的应用。
J Clin Microbiol. 2023 Mar 23;61(3):e0185922. doi: 10.1128/jcm.01859-22. Epub 2023 Feb 21.
5
Diagnosis and Antifungal Prophylaxis for COVID-19 Associated Pulmonary Aspergillosis.新型冠状病毒肺炎相关肺曲霉病的诊断与抗真菌预防
Antibiotics (Basel). 2022 Nov 26;11(12):1704. doi: 10.3390/antibiotics11121704.
本文引用的文献
1
Combination of Mycological Criteria: a Better Surrogate to Identify COVID-19-Associated Pulmonary Aspergillosis Patients and Evaluate Prognosis?联合应用真菌学标准：能否更好地确定 COVID-19 相关肺曲霉病患者并评估预后？
J Clin Microbiol. 2022 Mar 16;60(3):e0216921. doi: 10.1128/JCM.02169-21. Epub 2022 Jan 5.
2
Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study.COVID-19 机械通气患者真菌感染：法国多中心 MYCOVID 研究。
Lancet Respir Med. 2022 Feb;10(2):180-190. doi: 10.1016/S2213-2600(21)00442-2. Epub 2021 Nov 26.
3
Aspergillus Lateral Flow Assay with Digital Reader for the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis (CAPA): a Multicenter Study.用于 COVID-19 相关肺曲霉病 (CAPA) 诊断的曲霉侧向流检测与数字读取器：一项多中心研究。
J Clin Microbiol. 2022 Jan 19;60(1):e0168921. doi: 10.1128/JCM.01689-21. Epub 2021 Oct 13.
4
Aspergillus Test Profiles and Mortality in Critically Ill COVID-19 Patients.COVID-19 危重症患者曲霉检测谱与死亡率。
J Clin Microbiol. 2021 Nov 18;59(12):e0122921. doi: 10.1128/JCM.01229-21. Epub 2021 Sep 8.
5
Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology.2019冠状病毒病危重症患者肺曲霉病的危险因素及预后——欧洲医学真菌学联合会的一项多国观察性研究
Clin Microbiol Infect. 2022 Apr;28(4):580-587. doi: 10.1016/j.cmi.2021.08.014. Epub 2021 Aug 26.
6
Specificity Influences in (1→3)-β-d-Glucan-Supported Diagnosis of Invasive Fungal Disease.特异性对（1→3）-β-D-葡聚糖在侵袭性真菌病诊断中的影响
J Fungi (Basel). 2020 Dec 29;7(1):14. doi: 10.3390/jof7010014.
7
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.定义和管理新型冠状病毒肺炎相关肺曲霉病：2020年欧洲临床微生物与感染性疾病学会/国际人类与动物真菌学会研究和临床指南共识标准
Lancet Infect Dis. 2021 Jun;21(6):e149-e162. doi: 10.1016/S1473-3099(20)30847-1. Epub 2020 Dec 14.
8
Glucan rich nutrition does not increase gut translocation of beta-glucan.富含葡聚糖的营养物质并不会增加β-葡聚糖的肠道易位。
Mycoses. 2021 Jan;64(1):24-29. doi: 10.1111/myc.13161. Epub 2020 Nov 21.
9
Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19.新型冠状病毒肺炎（COVID-19）重症患者中疑似侵袭性肺曲霉病的患病率。
Lancet Respir Med. 2020 Jun;8(6):e48-e49. doi: 10.1016/S2213-2600(20)30237-X. Epub 2020 May 20.
10
Automation of serum (1→3)-beta-D-glucan testing allows reliable and rapid discrimination of patients with and without candidemia.血清（1→3）-β-D-葡聚糖检测的自动化可实现对有和无念珠菌血症患者的可靠和快速区分。
Med Mycol. 2014 Jul;52(5):455-61. doi: 10.1093/mmy/myu023. Epub 2014 Jun 6.
Zotero 插件